Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
10.45
+0.02 (0.19%)
Nov 21, 2024, 1:58 PM EST - Market open
Eton Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Cash & Equivalents | 20.26 | 21.39 | 16.31 | 14.41 | 21.3 | 12.07 | Upgrade
|
Cash & Short-Term Investments | 20.26 | 21.39 | 16.31 | 14.41 | 21.3 | 12.07 | Upgrade
|
Cash Growth | -8.20% | 31.17% | 13.18% | -32.35% | 76.49% | -54.87% | Upgrade
|
Receivables | 5.59 | 3.41 | 1.85 | 5.47 | 0.05 | 0.47 | Upgrade
|
Inventory | 1.94 | 0.91 | 0.56 | 0.55 | 1.24 | 0.38 | Upgrade
|
Prepaid Expenses | 1.96 | 1.13 | 1.29 | 3.18 | 2.12 | 1.09 | Upgrade
|
Other Current Assets | - | - | - | - | - | 1 | Upgrade
|
Total Current Assets | 29.75 | 26.84 | 20 | 23.6 | 24.7 | 15.01 | Upgrade
|
Property, Plant & Equipment | 0.23 | 0.15 | 0.26 | 0.22 | 1 | 1.28 | Upgrade
|
Other Intangible Assets | 5.85 | 4.74 | 4.75 | 3.62 | 0.58 | 0.73 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | 0.06 | Upgrade
|
Total Assets | 35.84 | 31.74 | 25.03 | 27.47 | 26.32 | 17.07 | Upgrade
|
Accounts Payable | 2.68 | 1.85 | 1.77 | 1.77 | 2.34 | 0.58 | Upgrade
|
Accrued Expenses | 12.93 | 8.96 | 3.66 | 1.37 | 1.17 | 1.39 | Upgrade
|
Current Portion of Long-Term Debt | - | 5.38 | 1.03 | 1.42 | 0.28 | - | Upgrade
|
Current Portion of Leases | - | 0.05 | - | - | - | - | Upgrade
|
Total Current Liabilities | 19.73 | 16.24 | 6.46 | 4.56 | 3.79 | 1.96 | Upgrade
|
Long-Term Debt | - | - | 5.38 | 5.26 | 6.76 | 4.54 | Upgrade
|
Long-Term Leases | 0.13 | 0.02 | 0.11 | 0.02 | 0.1 | 0.02 | Upgrade
|
Total Liabilities | 19.86 | 16.26 | 11.95 | 9.84 | 10.66 | 6.52 | Upgrade
|
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | Upgrade
|
Additional Paid-In Capital | 123.25 | 119.52 | 116.19 | 111.72 | 107.8 | 74.72 | Upgrade
|
Retained Earnings | -107.3 | -104.07 | -103.13 | -94.11 | -92.16 | -64.19 | Upgrade
|
Total Common Equity | 15.98 | 15.48 | 13.08 | 17.63 | 15.66 | 10.55 | Upgrade
|
Shareholders' Equity | 15.98 | 15.48 | 13.08 | 17.63 | 15.66 | 10.55 | Upgrade
|
Total Liabilities & Equity | 35.84 | 31.74 | 25.03 | 27.47 | 26.32 | 17.07 | Upgrade
|
Total Debt | 4.25 | 5.46 | 6.52 | 6.7 | 7.14 | 4.56 | Upgrade
|
Net Cash (Debt) | 16.01 | 15.93 | 9.78 | 7.71 | 14.15 | 7.51 | Upgrade
|
Net Cash Growth | -1.41% | 62.90% | 26.84% | -45.52% | 88.53% | -71.92% | Upgrade
|
Net Cash Per Share | 0.62 | 0.62 | 0.39 | 0.31 | 0.67 | 0.42 | Upgrade
|
Filing Date Shares Outstanding | 25.84 | 25.69 | 25.46 | 24.63 | 24.41 | 17.88 | Upgrade
|
Total Common Shares Outstanding | 25.84 | 25.69 | 25.35 | 24.63 | 24.31 | 17.88 | Upgrade
|
Working Capital | 10.02 | 10.6 | 13.54 | 19.05 | 20.91 | 13.05 | Upgrade
|
Book Value Per Share | 0.62 | 0.60 | 0.52 | 0.72 | 0.64 | 0.59 | Upgrade
|
Tangible Book Value | 10.13 | 10.74 | 8.32 | 14.01 | 15.09 | 9.83 | Upgrade
|
Tangible Book Value Per Share | 0.39 | 0.42 | 0.33 | 0.57 | 0.62 | 0.55 | Upgrade
|
Machinery | - | 0.35 | 0.34 | 0.4 | 1.32 | 1.3 | Upgrade
|
Construction In Progress | - | - | 0.01 | - | - | 0.01 | Upgrade
|
Leasehold Improvements | - | 0.1 | 0.07 | 0.07 | 0.18 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.